CY1107603T1 - Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης - Google Patents

Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης

Info

Publication number
CY1107603T1
CY1107603T1 CY20071100021T CY071100021T CY1107603T1 CY 1107603 T1 CY1107603 T1 CY 1107603T1 CY 20071100021 T CY20071100021 T CY 20071100021T CY 071100021 T CY071100021 T CY 071100021T CY 1107603 T1 CY1107603 T1 CY 1107603T1
Authority
CY
Cyprus
Prior art keywords
hematopoietic
growth hormone
thepapeies
myelovlastikes
epanametangisis
Prior art date
Application number
CY20071100021T
Other languages
English (en)
Inventor
Alessandro Massimo Gianni
Original Assignee
Laboratoires Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serono Sa filed Critical Laboratoires Serono Sa
Publication of CY1107603T1 publication Critical patent/CY1107603T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Η εφεύρεση αφορά το πεδίο της κινητοποίησης των αιματοποιητικών κυττάρων CD34+. Πιο συγκεκριμένα, η εφεύρεση αυτή αφορά μια μέθοδο για την αύξηση της κινητοποίησης των πολυδυναμικών αιματοποιητικών κυττάρων CD34+ με τη χορήγηση της ανθρώπινης ορμόνης ανάπτυξης ή ενός εκ των παραγώγων της στο άτομο.
CY20071100021T 1998-12-30 2007-01-08 Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης CY1107603T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
EP99965579A EP1140149B1 (en) 1998-12-30 1999-12-30 Use of human growth hormone to increase the number of circulating cd34+ cells, intended for reconstitution of the hematopoietic and immune systems following myeloablative or antiblastic therapies, by transplantation, re-infusion or engraftment

Publications (1)

Publication Number Publication Date
CY1107603T1 true CY1107603T1 (el) 2013-03-13

Family

ID=8233268

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100021T CY1107603T1 (el) 1998-12-30 2007-01-08 Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης

Country Status (15)

Country Link
US (1) US20060029581A1 (el)
EP (3) EP1016413A1 (el)
JP (1) JP4808316B2 (el)
AT (1) ATE342064T1 (el)
AU (2) AU772222B2 (el)
BR (1) BR9916726A (el)
CA (1) CA2354194A1 (el)
CY (1) CY1107603T1 (el)
DE (1) DE69933581T2 (el)
DK (1) DK1140149T3 (el)
ES (1) ES2275359T3 (el)
IL (2) IL143994A0 (el)
PT (1) PT1140149E (el)
SI (1) SI1140149T1 (el)
WO (1) WO2000040260A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001281800B2 (en) * 2000-06-07 2005-12-22 Merck Serono Sa Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
IL154159A0 (en) 2000-08-01 2003-07-31 Yissum Res Dev Co Directed differentiation of ebryonic cells
LT2371361T (lt) 2001-07-31 2019-09-10 Genzyme Corporation Pirmtakų/kamieninių ląstelių suaktyvinimo būdai
CA2540529C (en) 2003-10-03 2012-03-13 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
EP1833993A4 (en) * 2004-12-22 2009-07-22 Ambrx Inc HUMAN GROWTH HORMONE FORMULATIONS COMPRISING AN AMINO ACID CODED NON-NATURALLY
AU2010341518B2 (en) * 2009-12-21 2014-01-09 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
ES2172536T3 (es) * 1993-06-15 2002-10-01 British Biotech Pharm Liberacion y movilizacion de celulas hematopoyeticas.
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
JP3253966B2 (ja) * 1993-10-06 2002-02-04 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイテッド 幹細胞増殖因子
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
WO1997003684A1 (en) * 1995-07-21 1997-02-06 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
EP0877795A4 (en) * 1996-01-16 2003-03-05 Depuy Orthopaedics Inc INSULATION OF PROCUREMENT CELLS FROM HEMATOPOIETIC AND NON-HEMATOPOIETIC TISSUES AND THEIR USE
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
ES2226326T3 (es) * 1998-12-17 2005-03-16 Applied Research Systems Ars Holding N.V. Hormona de crecimiento humana para estimular la hematopoyesis y la reconstitucion del sistema inmune despues del trasplante de celulas madre hematopoyeticas en seres humanos.
AU2001281800B2 (en) * 2000-06-07 2005-12-22 Merck Serono Sa Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Also Published As

Publication number Publication date
WO2000040260A1 (en) 2000-07-13
DE69933581D1 (de) 2006-11-23
EP1140149B1 (en) 2006-10-11
US20060029581A1 (en) 2006-02-09
EP1140149A1 (en) 2001-10-10
AU2004203355B2 (en) 2007-05-17
ATE342064T1 (de) 2006-11-15
IL143994A (en) 2009-06-15
DE69933581T2 (de) 2007-06-21
EP1016413A1 (en) 2000-07-05
JP4808316B2 (ja) 2011-11-02
ES2275359T3 (es) 2007-06-01
CA2354194A1 (en) 2000-07-13
EP1779865A1 (en) 2007-05-02
AU2103900A (en) 2000-07-24
IL143994A0 (en) 2002-04-21
AU2004203355A1 (en) 2004-08-19
DK1140149T3 (da) 2007-02-19
JP2002534393A (ja) 2002-10-15
BR9916726A (pt) 2001-09-11
AU772222B2 (en) 2004-04-22
PT1140149E (pt) 2007-01-31
SI1140149T1 (sl) 2007-02-28

Similar Documents

Publication Publication Date Title
CY1107603T1 (el) Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης
ATE286118T1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
BRPI0413002A (pt) genes de ciclo de célula de planta e métodos de uso
CY1107778T1 (el) Ανθρωπινα cd45+ ή/και ινοβλαστης + μεσεγχυματικα βλαστικα κυτταρα
TR200001228T2 (tr) T yardımcı hücre tür 2 kökenli bağışıklık hastalıklarının retinoit antagonistlerle tedavisi
ATE199096T1 (de) Il-11 aus säugetier
DK240088A (da) Fremgangsmaade til transformation af et plantecellematerale
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
ES2053719T3 (es) Dimetilvermectinas no naturales y procedimiento para su preparacion.
MX9305150A (es) Filtro activo para reducir voltajes y corrientes no basicos.
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
ES2102081T3 (es) Inductores de parainmunidad multipotentes basados en combinaciones de componentes de poxvirus, metodos para preparar los mismos, y su uso como farmacos.
ATE255632T1 (de) Immortalisierung bzw. desimmortalisierung von zellen
BR112021019349A2 (pt) Células-tronco preparadas altamente funcionais
ATE198158T1 (de) Verfahren zur behandlung geschädigter und verminderter zellen
ATE514771T1 (de) Haartransplantation
FR2749022B1 (fr) Cellules aviaires immortelles
DE60032508D1 (de) VERFAHREN ZUR VERMEHRUNG VON NATüRLICHEN KILLERZELLEN
ATE226087T1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
AU4751797A (en) Defined systems for epithelial cell culture and use thereof
EP0765398A4 (en) POPULATION OF CELLS ENRICHED IN MYELOID AND / OR LYMPHOID PRECURSORS, PROCESSES FOR OBTAINING AND USING THE SAME
DK0925064T3 (da) 5-Androsten-3-beta,17-alpha-diol som inhibitor for tumorvækst
PT1016414E (pt) Hormona de crescimento humano para estimular a hematopoiese e a reconstituicao imnologica apos transplante de celulas estaminais hematopoieticas em humanos
AU4382297A (en) Plasmids containing two or more competitors in sequence and their application in competitive-pcr techniques
ITRM940359A0 (it) Dispositivo per il trasporto individuale di sci, racchette e simili.